BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults

In light of the decreasing immune protection against symptomatic SARS-CoV-2 infection after initial vaccinations and the now dominant immune-evasive Omicron variants, ‘booster’ vaccinations are regularly performed to restore immune responses. Many individuals have received a primary heterologous pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidel, Alina, Zanoni, Michelle, Groß, Rüdiger, Krnavek, Daniela, Erdemci-Evin, Sümeyye, von Maltitz, Pascal, Albers, Dan P. J., Conzelmann, Carina, Liu, Sichen, Weil, Tatjana, Mayer, Benjamin, Hoffmann, Markus, Pöhlmann, Stefan, Beil, Alexandra, Kroschel, Joris, Kirchhoff, Frank, Münch, Jan, Müller, Janis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357986/
https://www.ncbi.nlm.nih.gov/pubmed/35958601
http://dx.doi.org/10.3389/fimmu.2022.882918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357986/
https://www.ncbi.nlm.nih.gov/pubmed/35958601
http://dx.doi.org/10.3389/fimmu.2022.882918

Ejemplares similares